Symbol | Exchange | Currency |
|---|
Ocugen (NASDAQ:OCGN), Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics,...
Investing.com - Ocugen (NASDAQ: OCGN) reported fourth quarter EPS of $-0.100, in line with the analyst estimate of $-0.100. Revenue for the quarter came in at $0.00 versus the...
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
| Average | 4.833 (+423.651% Upside) |
| High | 8.000 |
| Low | 3.000 |
| Price | 0.923 |
| No. of Analysts | 6 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Neutral | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 151.80 | 153.40 | 151.40 | -1.60 | -1.04% | 2.60M | London | |||
| 215.00 | 221.00 | 210.00 | -5.00 | -2.27% | 624.35K | London | |||
| 133.90 | 137.74 | 130.06 | -5.88 | -4.21% | 122.87M | London | |||
| 1,030.00 | 1,030.00 | 1,030.00 | 0.00 | 0.00% | 30.79K | London | |||
| 222.50 | 224.50 | 220.00 | -2.50 | -1.11% | 312.84K | London | |||
| 103.05 | 104.30 | 102.30 | -1.70 | -1.62% | 24.54M | London | |||
| 1,100.00 | 1,160.00 | 1,079.00 | -40.00 | -3.51% | 289.75K | London | |||
| 0.1275 | 0.132 | 0.1305 | -0.0085 | -6.25% | 382.90M | London | |||
| 478.50 | 492.00 | 473.00 | -12.00 | -2.45% | 66.67K | London | |||
| 12.25 | 12.70 | 12.00 | +0.25 | +2.08% | 738.23K | London | |||
| 88.58 | 90.78 | 88.16 | -2.22 | -2.44% | 55.26M | London | |||
| 362.50 | 362.50 | 362.50 | -2.50 | -0.69% | 50.84K | London | |||
| 0.12 | 0.13 | 0.13 | 0.00 | 0.00% | 0.00 | Aquis Exchange | |||
| 262.60 | 280.00 | 261.60 | -10.70 | -3.92% | 1.30M | London | |||
| 94.50 | 92.40 | 92.40 | +2.10 | +2.27% | 193.60K | London |